Design and Evaluation of (223)Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy–Part I

Prostate cancer is the second most frequent malignancy in men worldwide. Unfortunately, current therapies often lead to the onset of metastatic castration-resistant prostate cancer (mCRPC), causing significant mortality. Therefore, there is an urgent need for new and targeted therapies that are adva...

Descripción completa

Detalles Bibliográficos
Autores principales: Czerwińska, Malwina, Fracasso, Giulio, Pruszyński, Marek, Bilewicz, Aleksander, Kruszewski, Marcin, Majkowska-Pilip, Agnieszka, Lankoff, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504699/
https://www.ncbi.nlm.nih.gov/pubmed/32887308
http://dx.doi.org/10.3390/ma13173875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504699/
https://www.ncbi.nlm.nih.gov/pubmed/32887308
http://dx.doi.org/10.3390/ma13173875

Ejemplares similares